Results 21 to 30 of about 22,657 (185)

Algorithm for the referral of patients with inflammatory back pain from primary care in Malaysia [PDF]

open access: yesMalaysian Family Physician, 2021
Chronic low back pain, defined as back pain lasting for more than three months, can be divided into mechanical or inflammatory back pain (IBP). IBP typically starts in patients below the age of 40, is improved with activity and worsens with rest.
Ing Soo Lau, Suk Chyn Gun, Swan Sim Yeap, Mollyza Mohd Zain, Habibah Mohd Yusoof, Sockalingam Sargunan, Fariz Yahya
doaj   +1 more source

Level of adherence to prescribed exercise in spondyloarthritis and factors affecting this adherence: a systematic review [PDF]

open access: yes, 2019
Adherence is a primary determinant of the effectiveness of any intervention. Exercise is considered essential in the management of spondyloarthritis (SpA); however, the overall adherence to exercise programmes and factors affecting adherence are unknown.
Coulter, EH   +4 more
core   +2 more sources

Persistencia de medicamentos biológicos durante ocho años en pacientes con artritis reumatoide y espondiloartritis [PDF]

open access: yes, 2019
Objective: To calculate the persistence, over a period of eight years, the retention rate of first and second-line of treatment with biological agents in patients with rheumatoid arthritis, spondyloarthritis and psoriatic arthritis and to compare ...
Balsa, Alejandro   +5 more
core   +3 more sources

S100A4 is elevated in axial spondyloarthritis: a potential link to disease severity

open access: yesBMC Rheumatology, 2020
Background S100A4 is a member of calcium binding S100 protein family well known for its role in cancer progression and metastasis. Nevertheless, S100A4 also serves as a negative regulator of bone formation. Dickkopf-1 (DKK-1), marker of bone remodelling,
Barbora Šumová   +12 more
doaj   +1 more source

Scotland Registry for Ankylosing Spondylitis (SIRAS) – Protocol [PDF]

open access: yes, 2016
Funding SIRAS was funded by unrestricted grants from Pfizer and AbbVie. The project was reviewed by both companies, during the award process, for Scientific merit, to ensure that the design did not compromise patient safety, and to assess the global ...
Dean, Linda E   +10 more
core   +1 more source

Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis

open access: yesReumatismo, 2013
In axial spondyloarthritis (SpA), the efficacy of certolizumab pegol (CZP), a novel pegylated anti-tumor necrosis factor alpha drug has not been investigated.
A. Spadaro   +6 more
doaj   +1 more source

Spondyloarthritis associated with inflammatory myositis: An unusual case report

open access: yesIndian Journal of Rheumatology, 2019
Spondyloarthritis is an inflammatory disorder of the axial skeleton, while inflammatory myositis is an inflammatory disease affecting the striated muscles. There is no usual association of spondyloarthritis and inflammatory myositis. A 35-year-old female
Pradip Kumar Prajapati
doaj   +1 more source

Ankylosing spondylitis and non-radiographic axial spondyloarthritis: Two stages of disease? [PDF]

open access: yesТерапевтический архив, 2017
Aim. To compare the clinical manifestations of ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nrAxSpA). Subjects and methods.
D G Rumyantseva   +6 more
doaj   +1 more source

Features of the course and outcomes of COVID-19 in patients with axial spondyloarthritis

open access: yesНаучно-практическая ревматология, 2022
The 2019 coronavirus disease pandemic (COVID-19) is particularly challenging not only for doctors, but also for patients with inflammatory diseases, including spondyloarthritis. Although a large number of studies have been conducted over the past 2 years
Sh. F. Erdes
doaj   +1 more source

Co-Occurrence and Characteristics of Patients With Axial Spondyloarthritis Who Meet Criteria for Fibromyalgia : Results From a UK National Register [PDF]

open access: yes, 2017
The British Society for Rheumatology (BSR) Biologics Register in Ankylosing Spondylitis is funded by the BSR and they have receive funds for this from Pfizer, AbbVie and UCB.
Atzeni, Fabiola   +8 more
core   +2 more sources

Home - About - Disclaimer - Privacy